Molecular dynamics simulation as a tool for assessment of drug binding property of human serum albumin

Mol Biol Rep. 2018 Dec;45(6):1647-1652. doi: 10.1007/s11033-018-4308-3. Epub 2018 Aug 18.

Abstract

Human serum albumin (HSA) is a major plasma protein and binding of drugs with this plasma protein has a great importance. It possess esterase activity which can cleave the drugs containing ester bond and thus, can regulate the effect of drugs. Till date no systematic study has been done to analyse binding of such drugs and to compare the results with the drugs which do not have ester bond. Therefore, in the present study two different categories-ester and non-ester drugs have been considered to analyse their interaction with HSA at two principle drug binding sites using molecular modelling tools. It is observed that the drugs irrespective of ester or non-ester nature prefer either Sudlow site I or II by hydrogen bond and hydrophobic interactions. The information obtained from the study can assist to study pharmacokinetics of the drugs and that in turn will help in noval drug discoveries.

Keywords: Drug–HSA interaction; Ester drug; Esterase activity; HSA; Non-ester drug.

MeSH terms

  • Binding Sites / drug effects
  • Esterases / drug effects
  • Humans
  • Hydrogen Bonding
  • Hydrophobic and Hydrophilic Interactions
  • Molecular Docking Simulation / methods*
  • Molecular Dynamics Simulation
  • Protein Binding / drug effects
  • Serum Albumin, Human / chemistry*
  • Serum Albumin, Human / metabolism*
  • Thermodynamics

Substances

  • Esterases
  • Serum Albumin, Human